This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Amyloidosis
E4_AMYLOIDOSIS
amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
715 |
4. Check minimum number of eventsNone |
715 |
5. Include endpoints |
727 |
6. Filter based on genotype QC (FinnGen only) |
727 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E70-E90
- Name in latin
- Amyloidosis
Similar endpoints
↥List of similar endpoints to
Amyloidosis
based on the number of shared cases.
Similar with more cases:
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 727 | 347 | 380 |
| Unadjusted period prevalence (%) | 0.14 | 0.12 | 0.17 |
| Median age at first event (years) | 67.78 | 63.02 | 72.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 622
- Matched controls
- 6221
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E85.9
ICD-10 Finland
Amyloidosis, unspecified
+∞
234.7
210
*
E85.4
ICD-10 Finland
Organ-limited amyloidosis
+∞
115.3
107
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
+∞
101.9
95
*
E85.80
ICD-10 Finland
Meretoja sick
+∞
101.9
95
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
+∞
99.7
93
*
E85.89
ICD-10 Finland
Other amyloidosis
+∞
92.0
86
*
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
77.8
73
*
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
+∞
77.8
73
*
H19.8*E85.80
ICD-10 Finland
Reticular keratitis in Meretoja's patients
+∞
70.1
66
*
C03CA01
ATC
furosemide; systemic
4.2
59.5
335
1362
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
25.7
56.1
79
35
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
23.1
55.7
81
40
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
33.6
52.8
69
23
A11CC03
ATC
alfacalcidol; systemic
23.4
49.2
71
34
XW000
NOMESCO Finland
Bone marrow biopsy
10.7
48.3
97
105
C90.0
ICD-10 Finland
Multiple myeloma
30.3
47.1
63
23
N08.4
ICD-10 Finland
Glomerular disorders in other endocrine, nutritional and metabolic diseases
+∞
45.4
43
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.1
45.3
100
128
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
44.7
370
1894
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
7.2
41.7
108
177
E85.0
ICD-10 Finland
Non-neuropathic heredofamilial amyloidosis
+∞
41.1
39
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
7.3
40.3
103
165
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
29.4
40.1
54
20
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
40.0
152
396
A12AA04
ATC
calcium carbonate; oral
26.2
38.2
53
22
Z49.1
ICD-10 Finland
Extracorporeal dialysis
31.1
37.0
49
17
TK800
NOMESCO Finland
Hemodialysis
20.6
35.5
53
28
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
39.3
35.1
44
12
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
8.1
35.1
82
114
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
39.8
32.9
41
11
N18.0
ICD-10 Finland
End-stage renal disease
42.6
32.5
40
10
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
28.7
31.9
43
16
2773B
ICD-9 Finland
Other and unspecified disorders of metabolism, Amyloidosis[AMYLOIDOSIS SECUNDARIA]
+∞
31.5
30
*
L04AA01
ATC
[U] ciclosporin; systemic
20.2
31.4
47
25
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
30.3
137
412
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
29.8
163
572
I50.9
ICD-10 Finland
Heart failure, unspecified
3.5
28.6
158
558
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
28.6
276
1416
153
Kela drug reimbursment
Lenalidomid
41.1
28.3
35
9
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
16.1
27.7
45
30
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
49.6
27.7
33
7
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
27.0
167
638
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
26.1
141
486
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
26.4
25.5
35
14
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
52.4
25.5
30
6
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
7.9
25.3
59
81
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
25.2
24
*
I43.1
ICD-10 Finland
Cardiomyopathy in metabolic diseases
+∞
25.2
24
*
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
18.3
24.7
38
22
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
24.6
187
812
L04AX04
ATC
lenalidomide; oral
50.5
24.5
29
6
N18.8
ICD-10 Finland
Other chronic renal failure
9.1
24.3
52
62
B03XA01
ATC
erythropoietin; parenteral
20.0
24.2
36
19
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
39.3
24.1
30
8
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
9.0
23.8
51
61
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.0
23.8
80
178
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.5
23.6
57
83
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
17.0
23.5
37
23
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.2
22.5
51
67
V03AE01
ATC
polystyrene sulfonate; oral
20.4
22.4
33
17
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
22.2
109
346
L01AA03
ATC
melphalan; systemic
64.9
22.0
25
*
H19.8
ICD-10 Finland
Other disorders of sclera and cornea in diseases classified elsewhere
+∞
22.0
21
*
M04AA01
ATC
allopurinol; systemic
3.1
22.0
137
516
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
10.9
21.9
42
41
B03XA02
ATC
darbepoetin alfa; parenteral
12.2
21.5
39
34
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
21.5
109
354
L04AX01
ATC
azathioprine; systemic
5.7
21.0
62
118
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
79.6
20.8
23
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
20.7
225
1179
H16.0
ICD-10 Finland
Corneal ulcer
5.7
20.7
61
116
N19
ICD-10 Finland
Unspecified kidney failure
6.5
20.6
55
92
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
19.1
20.6
31
17
137
Kela drug reimbursment
Uraemia requiring dialysis
19.1
20.6
31
17
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
33.8
20.3
26
8
AA1AD
NOMESCO Finland
CT of head and brain
2.5
20.1
190
919
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
19.9
90
265
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.7
19.6
69
161
H02AB02
ATC
dexamethasone; systemic
3.5
19.3
99
323
J01MA12
ATC
levofloxacin; systemic
2.7
19.2
158
706
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
56.9
19.0
22
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
35.6
19.0
24
7
ZX120
NOMESCO Finland
Intravenous
3.6
19.0
90
276
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.5
18.9
94
299
L99.0*E85.9
ICD-10 Finland
Amyloidosis of skin
+∞
18.8
18
*
127
Kela drug reimbursment
Transplant complication
15.7
18.6
30
20
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
18.4
67
161
C03DA01
ATC
spironolactone; oral
3.1
18.4
109
395
Z94.0
ICD-10 Finland
Kidney transplant status
20.1
18.3
27
14
L04AA06
ATC
mycophenolic acid; systemic
12.9
18.3
32
26
I50.0
ICD-10 Finland
Congestive heart failure
3.5
18.2
90
285
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
8.8
18.2
39
47
329
Kela drug reimbursment
Lenalidomide
54.2
18.1
21
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.4
18.0
68
170
E85.8
ICD-10 Finland
Other amyloidosis
+∞
17.8
17
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
17.5
89
288
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.1
17.0
68
179
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.8
16.7
74
214
9283
FHL
Subtalar joint ossification surgery (or triple)
174.4
16.6
17
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
15.9
16.3
26
17
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
16.3
285
1807
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
6.0
16.2
45
80
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
48.8
16.1
19
*
L04AA13
ATC
leflunomide; oral
7.1
16.0
39
58
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.5
15.8
37
52
ZXA05
NOMESCO Finland
Left side
2.2
15.7
203
1126
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
27.1
15.7
21
8
WX002
NOMESCO Finland
Sedation and analgesia
2.4
15.6
153
743
AA1AA
NOMESCO Finland
Head X-ray examination
13.5
15.3
26
20
CBJ50
NOMESCO Finland
Operation for ptosis of eyebrow
20.7
15.2
22
11
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
7.9
15.1
34
45
R06.0
ICD-10 Finland
Dyspnoea
2.2
15.0
177
935
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.2
15.0
84
291
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.9
15.0
63
174
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.8
14.9
50
111
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
21.7
14.7
21
10
H02AB06
ATC
prednisolone; systemic
2.0
14.6
319
2170
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
+∞
14.6
14
*
XF404
NOMESCO Finland
Ambulatory ECG
3.1
14.6
84
297
H02.2
ICD-10 Finland
Lagophthalmos
37.0
14.5
18
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
14.5
151
754
R80
ICD-10 Finland
Isolated proteinuria
17.5
14.4
22
13
9272
FHL
Metatarsophalangeal joint resection
27.9
14.3
19
7
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.5
14.3
51
121
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
43.5
14.2
17
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
14.1
47
104
WX892
NOMESCO Finland
Monitored bed care
3.5
14.0
67
207
A07EC01
ATC
sulfasalazine; oral, rectal
3.2
13.9
78
270
9314
FHL
Total knee endoprosthesis (also includes patellar part)
20.6
13.8
20
10
M01CB01
ATC
sodium aurothiomalate; parenteral
10.0
13.8
27
28
J05AB01
ATC
aciclovir; systemic
2.3
13.8
151
769
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.9
13.7
38
68
CG2T4
NOMESCO Finland
Topography assessment of cornea
15.1
13.7
22
15
R50.9
ICD-10 Finland
Fever, unspecified
2.6
13.7
108
463
L04AD01
ATC
ciclosporin; systemic
9.7
13.6
27
29
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
13.2
13.5
23
18
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.0
13.4
249
1581
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
21.7
13.4
19
9
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
13.4
91
356
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
13.1
179
1005
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
17.2
13.0
20
12
L88
ICPC
Rheumatoid/seropositive arthritis
4.8
13.0
43
94
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.9
13.0
36
64
E87.5
ICD-10 Finland
Hyperkalaemia
29.0
13.0
17
6
E86
ICD-10 Finland
Volume depletion
51.1
12.9
15
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
10.0
12.8
25
26
C07AB07
ATC
bisoprolol; oral
1.9
12.7
324
2286
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.7
12.7
43
97
9256
FHL
Synovectomy (knee 9311)
71.3
12.6
14
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
32.8
12.6
16
5
E83.50
ICD-10 Finland
Hypercalcemia
32.8
12.6
16
5
V03AE02
ATC
sevelamer; oral
32.8
12.6
16
5
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
12.6
204
1219
A04AA01
ATC
ondansetron; systemic, rectal
3.5
12.5
60
185
9284
FHL
Wrist ossification surgery
+∞
12.5
12
*
E85
ICD-10 Finland
Amyloidosis
+∞
12.5
12
*
E85.2
ICD-10 Finland
Heredofamilial amyloidosis, unspecified
+∞
12.5
12
*
B05DA
ATC
Isotonic solutions
13.5
12.5
21
16
ZXA00
NOMESCO Finland
Right side
2.0
12.5
200
1189
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
132.5
12.5
13
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
132.5
12.5
13
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.2
12.4
149
787
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.2
12.4
66
221
A46
ICD-10 Finland
Erysipelas
2.4
12.4
111
510
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
38.3
12.2
15
*
CG2S4
NOMESCO Finland
Photography of cornea
38.3
12.2
15
*
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
18.5
12.1
18
10
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
18.5
12.1
18
10
C10AA05
ATC
atorvastatin; oral
1.9
12.0
237
1520
L28
ICPC
Limited function/disability (L)
2.3
11.9
122
598
ZXA10
NOMESCO Finland
Bilateral
2.2
11.8
138
719
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.8
11.8
77
295
B01AB05
ATC
enoxaparin; parenteral
1.9
11.8
210
1298
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
16.8
11.7
18
11
R4120
NOMESCO Finland
Occupational therapy
3.5
11.7
56
173
QAJ10
NOMESCO Finland
Browlift
30.7
11.7
15
5
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
11.6
80
317
1XX32
NOMESCO Finland
NA
66.2
11.6
13
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
11.6
276
1882
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.5
11.6
23
25
H02.4
ICD-10 Finland
Ptosis of eyelid
5.2
11.6
35
70
N08.4*E85.80
ICD-10 Finland
Glomerular disease in Meretoja's patients
+∞
11.5
11
*
QAJ20
NOMESCO Finland
Subperiosteal facelift
+∞
11.5
11
*
2773A
ICD-9 Finland
Other and unspecified disorders of metabolism, Amyloidosis[AMYLOIDOSIS PRIMARIA]
+∞
11.5
11
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.3
11.4
57
182
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.5
11.3
95
420
A07AA09
ATC
vancomycin; oral
9.1
11.3
23
26
WW200
NOMESCO Finland
Immunization
6.4
11.3
29
47
H02.3
ICD-10 Finland
Blepharochalasis
3.2
11.0
58
193
H02AB04
ATC
methylprednisolone; systemic
2.3
11.0
109
524
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.1
10.9
42
108
ZX108
NOMESCO Finland
Inhalation
12.2
10.9
19
16
M05BA04
ATC
alendronic acid; oral
2.7
10.9
77
308
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.4
10.6
100
467
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
5.2
10.6
32
64
Z31.5
ICD-10 Finland
Genetic counselling
4.6
10.6
36
82
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.4
10.6
27
44
YNB10
NOMESCO Finland
Collection of stem cells for transplant
111.8
10.4
11
*
7143C
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]
+∞
10.4
10
*
E85.1
ICD-10 Finland
Neuropathic heredofamilial amyloidosis
+∞
10.4
10
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
33.1
10.4
13
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.0
10.3
21
24
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
10.2
27
46
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.9
10.2
63
233
A02BC02
ATC
pantoprazole; systemic
1.7
10.1
389
3037
R4110
NOMESCO Finland
Physiotherapy
1.9
10.0
168
1003
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
40.7
10.0
12
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
10.0
44
128
J01FF01
ATC
clindamycin; systemic
1.9
9.9
172
1042
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
12.4
9.9
17
14
L01AA01
ATC
cyclophosphamide; systemic
12.4
9.9
17
14
L04AA11
ATC
[U] etanercept; parenteral
20.4
9.8
14
7
ZX112
NOMESCO Finland
Subcutaneous
5.3
9.8
29
57
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
55.9
9.7
11
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.5
9.7
33
76
3AC01
NOMESCO Finland
NA
11.6
9.6
17
15
L01AA02
ATC
chlorambucil; oral
15.3
9.5
15
10
B01AB10
ATC
tinzaparin; parenteral
2.9
9.5
56
202
ACC51
NOMESCO Finland
Release of median nerve
2.9
9.5
56
202
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
9.5
64
251
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
9.5
150
877
TK810
NOMESCO Finland
Hemofiltration
17.9
9.4
14
8
Z49.2
ICD-10 Finland
Other dialysis
12.6
9.4
16
13
B05DB
ATC
Hypertonic solutions
12.6
9.4
16
13
27699
ICD-8 Finland
Amyloidosis
+∞
9.4
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
9.4
65
257
P01BA02
ATC
hydroxychloroquine; oral
2.6
9.3
69
286
N05CF01
ATC
zopiclone; oral
1.8
9.3
210
1384
H02.1
ICD-10 Finland
Ectropion of eyelid
6.9
9.2
22
33
B01AC04
ATC
clopidogrel; oral
2.2
9.2
104
529
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
9.2
104
529
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
11.7
9.1
16
14
S18
ICPC
Laceration/cut
1.7
9.1
260
1840
L04AC07
ATC
tocilizumab; parenteral
37.2
9.0
11
*
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
6.2
9.0
23
38
C09AA05
ATC
ramipril; oral
1.8
9.0
175
1096
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.6
9.0
30
68
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
18.9
9.0
13
7
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
18.9
9.0
13
7
QAJ30
NOMESCO Finland
Other facelift
24.4
8.9
12
5
CBF99
NOMESCO Finland
Other operation for ectropion
24.4
8.9
12
5
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
8.9
118
644
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.5
8.8
30
69
WX110
NOMESCO Finland
Local anesthesy
1.7
8.8
365
2857
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
6.1
8.8
23
39
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.6
8.8
38
109
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
8.8
56
213
9289
FHL
Other measure in this category
50.7
8.7
10
*
WW409
NOMESCO Finland
Other aferesis
50.7
8.7
10
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
4.6
8.6
29
66
B01AB04
ATC
dalteparin; parenteral
3.3
8.6
42
133
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
8.6
370
2917
G51.0
ICD-10 Finland
Bell palsy
5.3
8.6
25
49
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
8.5
51
186
XF402
NOMESCO Finland
ECG with work load test
2.4
8.5
77
352
NDG74
NOMESCO Finland
Fusion of first IP joint
27.9
8.5
11
*
L01CB
ATC
Podophyllotoxin derivatives
27.9
8.5
11
*
RS221
NOMESCO Finland
NA
7.5
8.5
19
26
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
20.3
8.5
12
6
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
20.3
8.5
12
6
S97
ICPC
Chronic ulcer skin
3.1
8.5
45
152
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
8.4
95
483
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
8.4
95
483
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.4
8.4
29
68
NDG30
NOMESCO Finland
Fusion of wrist, total
13.0
8.4
14
11
S01AD03
ATC
aciclovir; ophthalmic
3.8
8.4
34
93
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
8.4
86
420
J01DA01
ATC
[U] cefalexin; systemic
1.7
8.4
374
2968
I42.5
ICD-10 Finland
Other restrictive cardiomyopathy
+∞
8.3
8
*
J01MA14
ATC
moxifloxacin; systemic
2.5
8.3
68
295
ZZH31
NOMESCO Finland
Bone allograft, small pieces
9.6
8.3
16
17
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
8.3
73
329
B01AA03
ATC
warfarin; systemic
1.8
8.2
156
966
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
6.6
8.2
20
31
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
6.2
8.2
21
35
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
8.1
72
325
L04AB04
ATC
adalimumab; parenteral
8.3
8.1
17
21
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
8.1
58
235
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
33.8
8.1
10
*
L01BB01
ATC
NA
33.8
8.1
10
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.3
8.1
73
336
R60.0
ICD-10 Finland
Localized oedema
2.2
8.1
80
385
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
7.4
8.0
18
25
RD210
NOMESCO Finland
NA
7.9
7.9
17
22
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
7.9
57
232
RS220
NOMESCO Finland
NA
9.6
7.8
15
16
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
3.1
7.8
41
138
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
7.7
44
155
C08CA01
ATC
amlodipine; oral
1.7
7.7
229
1615
CBN30
NOMESCO Finland
Shortening of canthal ligament
12.0
7.6
13
11
9522
FHL
Synovectomy
25.3
7.6
10
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
7.6
74
353
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
7.6
58
244
RS222
NOMESCO Finland
NA
9.0
7.6
15
17
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
7.6
110
620
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.8
7.6
30
81
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
7.4
193
1310
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
81.0
7.4
8
*
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
5.7
7.4
20
36
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
7.4
70
328
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.8
7.3
46
172
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
+∞
7.3
7
*
SPAT1229
SPAT
Assessment of need for aid
2.4
7.3
60
264
H26.2
ICD-10 Finland
Complicated cataract
5.9
7.3
19
33
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
7.3
216
1520
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.7
7.3
47
181
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
16.0
7.2
11
7
H02AB07
ATC
prednisone; oral
2.0
7.2
102
568
C09CA01
ATC
losartan; oral
1.7
7.2
156
1003
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.8
7.2
43
158
C10AA01
ATC
simvastatin; oral
1.6
7.2
264
1965
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
30.4
7.2
9
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
30.4
7.2
9
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
30.4
7.2
9
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
30.4
7.2
9
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
20.3
7.1
10
5
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
20.3
7.1
10
5
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
7.1
52
212
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
7.1
56
241
J01DB01
ATC
cefalexin; oral
1.7
7.1
466
4003
M01CB03
ATC
auranofin; oral
10.2
7.1
13
13
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
7.1
7.0
16
23
H02AB09
ATC
hydrocortisone; systemic
5.6
7.0
19
35
XX9XE
NOMESCO Finland
Other ultrasound examination
7.7
6.9
15
20
E87.6
ICD-10 Finland
Hypokalaemia
7.7
6.9
15
20
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
14.0
6.9
11
8
H26.3
ICD-10 Finland
Drug-induced cataract
14.0
6.9
11
8
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.8
6.9
44
167
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
40.5
6.8
8
*
CBH25
NOMESCO Finland
Tarsorrhaphy
40.5
6.8
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.8
125
764
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.8
117
700
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.7
96
536
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.5
6.7
22
50
JN4AD
NOMESCO Finland
Body CT examination
2.4
6.7
54
236
N02AA05
ATC
oxycodone; systemic
1.9
6.7
103
591
ZZC00
NOMESCO Finland
Graft of fascia
22.8
6.7
9
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
22.8
6.7
9
*
H02AB08
ATC
triamcinolone; systemic
22.8
6.7
9
*
K65.0
ICD-10 Finland
Acute peritonitis
6.0
6.6
17
29
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
7.9
6.6
14
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
6.6
180
1230
H18.4
ICD-10 Finland
Corneal degeneration
12.4
6.6
11
9
D06BB04
ATC
podophyllotoxin; topical
3.6
6.6
28
81
UJF32
NOMESCO Finland
Coloscopy
1.7
6.5
157
1035
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.5
153
1005
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
6.5
98
559
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
6.5
71
357
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
6.5
83
445
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.8
6.5
20
43
212
Kela drug reimbursment
Gout
4.1
6.5
23
57
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
6.4
103
600
QAJ15
NOMESCO Finland
Browlift using video-endoscope
70.5
6.4
7
*
M05.2
ICD-10 Finland
Rheumatoid vasculitis
70.5
6.4
7
*
M43.4
ICD-10 Finland
Other recurrent atlantoaxial subluxation
70.5
6.4
7
*
J05AB11
ATC
valaciclovir; oral
2.1
6.4
75
388
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
14.5
6.4
10
7
TK820
NOMESCO Finland
Peritoneal dialysis
14.5
6.4
10
7
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
3.3
6.4
30
94
TQW40
NOMESCO Finland
Remowal of suture of skin
2.5
6.4
48
202
L04AB01
ATC
etanercept; parenteral
5.6
6.3
17
31
N19
ICPC
Speech disorder
11.2
6.3
11
10
NHG20
NOMESCO Finland
Fusion of talocrural joint
9.4
6.3
12
13
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
6.3
78
413
N084, E853
ICD-10 Finland
NA
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
3.7
6.2
25
69
L04AA17
ATC
[U] adalimumab; parenteral
27.0
6.2
8
*
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
27.0
6.2
8
*
V03AE03
ATC
lanthanum carbonate; oral
27.0
6.2
8
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.2
101
590
E0000UV
ATC
NA
1.6
6.2
222
1624
H03AA01
ATC
levothyroxine sodium; systemic
1.7
6.2
128
809
B80
ICPC
Iron deficiency anaemia
5.8
6.2
16
28
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
2.9
6.1
36
131
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
6.1
43
173
R11
ICD-10 Finland
Nausea and vomiting
2.4
6.1
49
212
104
Kela drug reimbursment
Thyroid insufficiency
2.5
6.1
46
194
E000001
ATC
NA
1.7
6.1
122
762
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
6.8
6.1
14
21
S01XA18
ATC
ciclosporin; ophthalmic
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494890) Protein electrophoresis panel - 24 hour Urine
145
50
35.98
223.56
4.5
2.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
214
191
15.46
214.92
12.2
3.4
ratio
1.7
2.1
0.17
15
18
(3034860) Kappa light chains.free [Mass/volume] in Serum
216
196
15.26
214.74
12.4
3.5
mg/l
67.6
82.5
0.16
187
163
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
216
196
15.26
214.74
12.4
3.5
mg/l
65.9
50.4
0.40
186
166
(40760888) Immunoglobulin light chains.free panel - Serum
185
147
16.54
198.21
11.1
3.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
102
20
59.16
180.32
2.9
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
169
136
15.89
179.04
2.9
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
252
432
8.40
152.08
7.7
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
267
518
7.57
142.83
8.0
2.6
g/l
63.0
66.1
5.74
254
472
(3003458) Phosphate [Moles/volume] in Serum or Plasma
270
655
5.97
111.87
11.5
5.0
mmol/l
1.1
1.0
6.18
261
594
(3017817) Protein [Mass] in Urine collected for unspecified duration
86
50
19.37
106.57
4.1
2.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
214
447
6.37
103.41
11.9
6.2
mmol/l
13.0
10.6
3.64
205
418
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
151
239
7.71
95.16
8.1
2.2
g/l
7.3
7.3
0.20
117
186
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
150
239
7.65
93.90
8.2
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
150
239
7.65
93.90
8.2
2.2
g/l
3.4
3.7
1.54
112
180
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
145
224
7.84
93.31
8.1
2.2
g/l
9.0
10.6
2.41
120
195
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
143
225
7.67
90.40
8.5
2.2
g/l
2.9
3.2
2.34
113
183
(3005719) IgG [Mass/volume] in Serum or Plasma
184
387
6.03
87.21
4.5
2.9
g/l
9.2
11.1
4.11
173
358
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
134
206
7.75
86.34
8.3
2.4
g/l
1.6
1.8
0.19
120
181
(3028026) IgM [Mass/volume] in Serum or Plasma
157
305
6.29
80.51
4.0
1.6
g/l
1.3
1.6
0.42
147
277
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
235
658
4.80
79.23
5.9
4.5
u/l
243.8
244.4
0.03
228
627
(3042111) Morphology [Interpretation] in Bone marrow Narrative
89
103
9.71
72.13
1.2
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
114
183
7.20
70.10
8.1
2.3
g/l
0.0
0.0
0.92
109
169
(3023520) Reticulocytes [#/volume] in Blood
192
508
4.78
68.60
2.6
2.8
e9/l
65.8
68.9
0.59
153
400
(3027945) Reticulocytes/100 erythrocytes in Blood
225
679
4.35
67.71
2.9
2.6
%
1.7
1.8
0.58
208
611
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
114
194
6.78
66.20
8.0
2.2
g/l
36.1
37.0
0.68
105
170
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
106
172
7.04
64.35
8.5
2.4
g/l
0.0
0.0
0.00
101
160
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
106
175
6.92
63.28
8.5
2.3
g/l
0.0
0.0
0.50
101
161
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
164
423
4.72
59.91
5.9
3.1
ng/l
126.4
88.7
1.00
142
364
(3045142) Bone marrow Pathology biopsy report
65
68
10.40
56.48
1.2
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
224
761
3.81
55.89
4.8
2.3
%
20.5
22.3
1.32
200
659
(3017704) Immunofixation for Urine
51
38
14.36
54.99
3.3
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
228
803
3.68
53.65
4.7
2.2
g/l
2.1
2.3
3.95
221
744
(3012095) Magnesium [Moles/volume] in Serum or Plasma
226
821
3.54
50.32
5.3
3.3
mmol/l
0.8
0.8
0.89
217
764
(3022948) Iron [Moles/volume] in Serum or Plasma
235
882
3.46
49.61
4.7
2.3
umol/l
10.7
12.7
4.79
227
820
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
36
16
23.62
49.43
1.1
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
222
809
3.51
49.04
3.2
1.9
s
29.7
29.8
0.07
215
778
(42870588) Differential panel, method unspecified - Blood
365
1813
3.03
47.22
10.1
5.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
365
1856
2.94
44.55
8.0
3.0
ng/l
3710.7
1528.4
7.38
342
1586
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
456
2630
2.97
43.68
14.5
5.2
mmol/l
1.2
1.2
0.45
431
2356
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
483
2883
3.01
43.24
18.0
5.9
mmol/l
1.2
1.2
1.41
413
2439
(3013115) Eosinophils [#/volume] in Blood
469
2760
2.97
43.02
11.8
5.6
e9/l
0.2
0.2
1.41
429
2415
(3026493) Urate [Moles/volume] in Serum or Plasma
304
1424
2.95
42.82
5.7
2.6
umol/l
382.2
8353.8
6.37
278
1198
(3006315) Basophils [#/volume] in Blood
459
2677
2.94
42.69
11.7
5.4
e9/l
0.0
0.0
0.24
424
2304
(3001604) Monocytes [#/volume] in Blood
456
2665
2.91
41.98
11.6
5.4
e9/l
0.6
0.6
2.00
420
2284
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
110
272
4.59
41.62
1.9
2.0
g/l
1.5
1.5
0.12
96
234
(3024561) Albumin [Mass/volume] in Serum or Plasma
437
2506
2.86
41.56
10.8
4.3
g/l
32.4
35.1
14.03
414
2303
(3019198) Lymphocytes [#/volume] in Blood
461
2725
2.89
41.25
11.7
5.5
e9/l
1.7
1.9
2.37
426
2395
(3019069) Monocytes/100 leukocytes in Blood
436
2530
2.81
39.96
12.1
5.8
%
8.9
8.8
0.20
416
2355
(3022096) Basophils/100 leukocytes in Blood
425
2439
2.79
39.73
11.6
5.6
%
0.7
0.7
0.00
406
2262
(46235355) HIV 1 and 2 tests - Meaningful Use set
171
598
3.43
39.47
1.9
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
433
2514
2.79
39.47
11.7
5.6
%
2.6
2.9
1.61
414
2327
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
154
509
3.57
38.78
2.0
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
438
2574
2.77
38.71
11.8
5.7
%
24.2
27.0
5.38
416
2374
(3017143) Hepatitis C virus Ab [Presence] in Serum
143
458
3.64
37.71
2.0
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
431
2538
2.71
37.51
11.2
5.5
%
61.3
57.9
6.62
409
2363
(3018418) pH of Serum or Plasma
326
1703
2.66
35.72
12.8
3.6
ph
7.4
7.4
0.37
74
323
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
39
5
82.42
35.18
1.3
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
219
961
2.83
33.50
2.4
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
213
922
2.85
33.43
3.4
1.3
g/l
2.2
2.6
1.63
166
534
(3023368) Bacteria identified in Blood by Culture
312
1643
2.57
33.02
6.7
4.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
314
1683
2.52
31.71
3.0
2.0
u/l
166.5
242.6
0.87
294
1581
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
77
179
4.69
31.21
3.7
2.5
u/ml
0.3
0.3
0.36
48
98
(3013650) Neutrophils [#/volume] in Blood by Automated count
479
3131
2.55
31.15
17.8
8.8
e9/l
4.6
4.1
3.66
440
2735
(3021879) Hepatitis B virus core Ab [Presence] in Serum
105
310
3.79
30.94
1.6
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
361
2104
2.42
29.83
5.1
3.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
36
9
42.02
29.24
1.1
1.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
33
5
68.96
29.15
4.2
3.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
55
101
5.81
29.08
4.6
5.4
iu/ml
1117.7
208.8
0.53
13
14
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
115
380
3.41
28.48
2.2
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
80
208
4.20
28.05
3.8
2.9
g/l
0.6
0.3
2.40
48
77
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
84
230
4.00
27.45
6.9
3.6
mmol/l
24.5
24.3
0.19
75
202
(3033658) Prothrombin time (PT) actual/Normal
259
1345
2.44
27.16
6.0
3.6
%
86.3
87.4
0.26
254
1309
(3002032) Base excess in Venous blood by calculation
131
484
3.08
26.89
6.8
3.2
mmol/l
2.3
2.2
0.04
112
378
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
371
2263
2.31
26.68
7.5
3.4
ng/l
63.6
49.4
0.41
318
1667
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
105
343
3.41
26.40
5.8
3.4
mmol/l
1.3
2.1
1.28
80
263
(3000991) Gas panel - Venous blood
120
429
3.15
26.02
8.8
7.8
—
—
—
0
0
(3009343) pH of Capillary blood
107
362
3.29
25.40
5.9
3.4
ph
7.4
7.4
0.07
16
44
(21494434) Karyotype in Bone marrow
40
62
6.77
24.96
1.2
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
55
116
5.05
24.95
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
271
1487
2.31
24.59
2.6
2.1
mg/l
3.1
3.3
0.64
242
1258
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
107
369
3.23
24.58
5.9
3.3
kpa
5.0
5.2
2.11
100
340
(3026782) Osmolality of Urine
224
1132
2.41
24.56
3.9
2.6
mosm/kgh2o
496.2
558.6
5.20
194
951
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
66
164
4.33
24.51
1.3
1.4
g/l
1.2
1.1
0.32
61
159
(3002582) Erythrocytes [#/volume] in Urine
303
1756
2.24
23.97
4.9
3.1
e6/l
46.5
121.0
1.09
267
1377
(3044927) Protein electrophoresis panel - Urine
41
69
6.24
23.64
1.9
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
356
2210
2.20
23.64
4.5
2.6
ug/l
187.1
149.9
2.28
330
2008
(3007853) Bacteria identified in Skin by Aerobe culture
150
637
2.71
23.61
2.3
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
154
663
2.68
23.59
2.2
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
285
1622
2.25
23.45
4.8
3.0
e6/l
0.4
0.5
0.27
249
1248
(3036489) Thrombin time
64
161
4.26
23.37
2.7
2.0
s
22.6
21.4
1.36
56
147
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
130
522
2.81
22.74
5.2
3.0
ng/l
460.2
227.7
3.24
120
483
(4035726)
127
506
2.83
22.53
1.4
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
151
661
2.62
22.27
2.2
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
67
6.09
22.02
1.2
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
272
1553
2.20
21.89
4.7
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
433
2957
2.15
21.89
9.1
6.1
umol/l
10.8
12.0
1.77
422
2797
(3018095) Leukocytes [#/volume] in Urine
329
2026
2.14
21.79
5.7
3.5
e6/l
72.3
151.4
1.13
273
1476
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
34
52
6.81
21.46
3.1
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
176
842
2.44
21.44
3.1
2.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
22
19
11.91
21.44
1.9
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
45
91
5.21
21.39
1.6
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
468
3337
2.13
20.55
8.6
4.4
mmol/l
6.6
6.7
0.30
451
3114
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
58
150
4.12
20.39
2.0
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
208
1093
2.26
20.28
8.9
3.7
ng/l
242.2
355.2
0.51
195
891
(3012516) Albumin [Mass/volume] in Urine
283
1683
2.12
20.16
5.6
3.0
mg/l
2418.7
309.5
3.35
215
1041
(3032080) INR in Blood by Coagulation assay
372
2448
2.06
20.15
12.4
9.8
inr
1.3
1.3
0.27
99
671
(1616796) Gas panel - Central venous blood
48
109
4.64
19.92
6.0
3.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
145
662
2.49
19.39
1.4
1.3
titre
558.7
528.5
0.08
30
146
(3000850) Epithelial cells [#/volume] in Urine
227
1261
2.16
19.12
3.7
2.4
e6/l
4.3
5.1
0.77
211
1109
(40758558) Short blood count panel - Blood
236
1332
2.14
19.07
12.2
6.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
146
3.99
18.66
2.0
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
64
189
3.62
18.65
3.6
2.1
ug/l
658.4
512.1
0.15
59
177
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95
357
2.91
18.63
1.9
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
33
57
6.02
18.52
1.5
1.2
mmol/l
51.2
65.5
1.40
25
44
(3009508) Creatinine [Moles/volume] in Urine
284
1735
2.05
18.45
4.3
2.9
mmol/l
5.8
7.4
10.76
253
1430
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
56
152
3.91
18.42
1.4
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
114
480
2.63
17.97
5.4
4.2
%
1.1
0.9
0.22
53
156
(3002179) Metamyelocytes/100 leukocytes in Blood
106
431
2.71
17.90
4.9
4.1
%
0.4
0.4
0.13
41
115
(3015377) Calcium [Moles/volume] in Serum or Plasma
311
1985
1.99
17.67
5.0
3.3
mmol/l
2.3
2.4
1.62
268
1698
(3000494) Fungus identified in Specimen by Culture
136
633
2.41
17.30
1.8
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
112
476
2.60
17.29
6.3
6.5
mmol/l
1.3
1.4
0.92
107
456
(3037467) Urinalysis macro (dipstick) panel - Urine
510
3881
2.05
17.19
7.2
4.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
286
1786
1.99
17.19
5.3
3.7
mg/mmol
71.0
7.0
8.12
214
1086
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
132
611
2.42
16.98
3.2
2.6
umol/l
7.2
9.4
0.94
119
527
(3012441) Differential panel - Pleural fluid
36
74
5.07
16.78
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
202
1122
2.11
16.69
2.1
1.6
mg/l
1.9
1.3
0.55
155
862
(3021440) Promyelocytes/100 leukocytes in Blood
106
449
2.59
16.44
5.6
4.3
%
0.1
0.1
0.54
50
140
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
170
888
2.19
16.41
4.0
2.9
e6/l
3.5
2.2
0.84
110
495
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
66
216
3.26
16.38
1.3
1.9
u/l
38.3
39.2
0.10
53
190
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
333
2226
1.92
16.08
3.1
2.1
nmol/l
75.6
79.3
1.65
311
1939
(3003434) Protein [Mass/volume] in Pleural fluid
42
103
4.27
15.82
1.6
1.4
g/l
24.8
31.8
2.61
34
93
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
41
100
4.29
15.55
1.1
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
100
427
2.56
15.22
2.2
2.0
nmol/l
370.6
373.3
0.04
92
385
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
163
3.50
15.21
2.1
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
112
510
2.41
14.84
2.3
2.2
g/l
0.2
0.2
1.12
107
477
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
36
83
4.51
14.66
1.6
1.4
u/ml
117.0
106.8
—
5
11
(3044640) Blood type and Crossmatch panel - Blood
273
1750
1.90
14.65
3.5
2.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
75
4.71
14.60
6.1
2.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
41
105
4.08
14.59
1.6
2.5
umol/l
36.2
35.5
0.04
34
88
(3022313) Gas panel - Capillary blood
72
269
2.86
14.20
5.7
3.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
544
4365
1.98
14.10
15.9
7.2
u/l
82.4
79.2
0.85
526
4053
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
37
6.39
13.81
1.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
52
164
3.34
13.68
1.3
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
522
4150
1.91
13.66
7.8
4.0
mm/h
19.7
13.3
10.36
493
3793
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
106
3.94
13.60
2.1
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
205
1220
1.95
13.59
2.0
1.7
nmol/l
1080.6
1188.5
0.82
162
910
(40758292) HTLV I+II Ab panel - Serum
14
12
11.88
13.56
1.7
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
23
38
6.22
13.46
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
173
974
2.02
13.43
3.8
2.7
e6/l
1.2
1.2
0.01
112
576
(3025159) Blasts/100 leukocytes in Blood
96
426
2.44
13.41
5.8
4.3
%
0.0
0.8
0.57
44
119
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
31
68
4.72
13.41
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
36
90
4.16
13.23
1.4
1.4
e6/l
692.7
1258.0
1.17
26
66
(3004809) Band form neutrophils/100 leukocytes in Blood
37
95
4.05
13.13
3.1
4.3
%
0.8
0.9
0.07
31
81
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
34
82
4.30
13.09
7.3
6.0
mg/l
13.3
11.7
1.23
34
75
(3028308) Erythrocytes [#/volume] in Pleural fluid
34
83
4.25
12.89
1.4
1.3
e6/l
48180.1
93976.4
0.26
15
51
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
37
98
3.92
12.59
5.2
3.1
%
58.2
58.2
0.01
37
98
(3012501) Base excess in Blood by calculation
40
113
3.69
12.43
5.7
3.8
mmol/l
2.1
2.9
1.11
28
74
(3003396) Base excess in Arterial blood by calculation
129
669
2.13
12.42
7.7
6.8
mmol/l
0.9
1.4
0.78
102
497
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
129
670
2.12
12.37
7.8
6.8
kpa
4.8
5.1
2.46
121
632
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
216
1343
1.87
12.36
3.5
2.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
65
4.61
12.23
1.9
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
266
1776
1.78
11.98
3.7
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
35
93
3.90
11.86
5.3
2.7
e9/l
4.7
4.5
0.18
35
93
(3027801) Oxygen [Partial pressure] in Arterial blood
127
671
2.08
11.60
7.9
6.8
kpa
12.0
11.9
0.03
119
633
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
11
11.08
11.08
10.7
12.5
mmol/l
4.8
6.4
0.80
12
11
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
62
4.48
11.06
2.0
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
333
2413
1.70
10.94
21.0
9.3
e9/l
0.0
0.0
0.21
284
1962
(40768806) Pleura Pathology biopsy report
32
85
3.89
10.86
1.4
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
40
125
3.33
10.69
1.5
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
103
518
2.15
10.66
2.6
2.3
ug/l
4.9
7.1
1.50
85
454
(40760892) CBC W Ordered Manual Differential panel - Blood
184
1134
1.83
10.61
9.0
4.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
33
5.89
10.58
1.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
33
5.89
10.58
1.4
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
140
793
1.95
10.46
27.3
27.1
inr
1.4
1.4
0.04
16
119
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
37
5.53
10.45
1.5
1.4
g/l
1.6
3.1
2.84
15
27
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
254
1728
1.72
10.40
3.0
2.3
u/l
61.1
57.2
0.63
234
1578
(3021788) Differential panel - Synovial fluid
37
112
3.43
10.40
2.2
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
241
1618
1.73
10.34
4.2
3.0
u/l
31.7
32.3
0.11
229
1520
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
217
2.71
10.31
2.0
3.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
118
3.34
10.26
5.0
2.2
%
14.7
15.6
0.54
21
57
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
351
2609
1.67
10.26
5.7
4.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
61
248
2.59
10.21
2.6
1.9
ug/l
1.1
3.2
1.04
56
218
(3045788) Cell count panel - Pleural fluid
28
71
4.06
10.12
1.6
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
63
4.24
9.97
1.6
1.9
g/l
0.6
0.9
0.45
19
49
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
28
6.19
9.96
1.2
1.9
%
16.4
15.5
—
5
14
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
333
2460
1.65
9.84
2.5
2.0
pmol/l
92.3
95.7
0.63
190
1261
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
29
5.98
9.63
2.4
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
29
5.98
9.63
2.4
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
29
5.98
9.63
2.4
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
29
5.98
9.63
2.4
2.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
32
93
3.55
9.57
1.7
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
33
5.57
9.49
3.6
2.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
34
104
3.38
9.41
4.8
2.5
—
—
—
0
0
(4062490)
19
37
5.25
9.40
1.5
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
37
5.25
9.40
1.5
1.4
g/l
9.1
7.1
0.43
14
26
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
37
5.25
9.40
1.5
1.4
g/l
0.2
0.4
1.01
14
26
(3035880) pH of Pleural fluid
20
41
4.99
9.36
1.6
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
28
76
3.79
9.24
3.0
2.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
41
143
2.98
9.16
2.1
1.7
e6/l
19902.7
14570.9
0.35
32
103
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
117
3.19
9.06
1.7
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
12
9.29
9.00
1.3
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
112
619
1.96
8.92
5.8
3.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
47
4.57
8.88
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
189
1233
1.72
8.77
5.0
3.9
—
—
—
0
0
(44790049)
27
75
3.70
8.63
1.6
1.5
—
—
—
0
0
(44806118)
27
75
3.70
8.63
1.6
1.5
—
—
—
0
0
(44790047)
27
75
3.70
8.63
1.6
1.5
—
—
—
0
0
(44790048)
27
75
3.70
8.63
1.6
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
64
289
2.33
8.57
7.7
9.0
mmol/l
24.0
24.7
0.83
59
267
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
22
6.47
8.55
2.5
2.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
22
6.47
8.55
2.5
2.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
71
3.76
8.51
3.2
4.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
57
246
2.43
8.44
2.5
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
96
3.33
8.43
1.5
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
356
2744
1.58
8.39
5.4
3.7
estimate
0.0
0.0
0.80
82
521
(3021960) Folate [Moles/volume] in Serum or Plasma
217
1484
1.66
8.39
1.9
1.5
nmol/l
21.0
20.9
0.05
193
1232
(3035350) Ketones [Presence] in Urine by Test strip
352
2710
1.58
8.32
5.4
3.7
estimate
0.0
0.0
0.00
84
526
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
54
4.17
8.31
2.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
54
4.17
8.31
2.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
54
4.17
8.31
2.2
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
36
124
3.00
8.23
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
36
124
3.00
8.23
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
23
6.19
8.20
2.5
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
44
170
2.69
8.17
4.4
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
114
3.08
8.14
2.3
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
350
2702
1.57
8.10
7.1
5.0
estimate
0.0
0.0
0.00
90
529
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
20
6.60
8.09
1.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
120
3.01
8.07
4.6
2.0
g/l
116.1
126.9
1.54
27
89
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
62
284
2.29
8.03
11.0
9.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
87
457
2.03
7.98
3.0
2.8
ml/min/173m2
44.9
62.1
3.65
48
172
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
105
3.14
7.94
1.8
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
340
2.17
7.88
1.5
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
299
2243
1.57
7.75
2.5
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
52
225
2.41
7.66
2.0
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
12
8.44
7.59
1.5
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
25
5.69
7.56
1.2
2.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
15
29
5.26
7.47
2.4
2.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
167
2.61
7.39
1.7
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
64
3.68
7.35
3.5
4.3
%
57.1
50.7
0.63
18
48
(3024928) Oxygen saturation in Venous blood
31
105
3.04
7.31
5.0
2.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
58
269
2.26
7.31
5.7
2.7
mmol/l
24.7
25.3
0.56
58
259
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
7
0
+∞
7.30
1.0
0.0
ug/g
174.0
—
—
7
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
34
122
2.87
7.26
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
29
95
3.14
7.23
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
30
5.08
7.21
1.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
30
5.08
7.21
1.5
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
38
4.56
7.21
1.4
3.1
%
20.8
38.1
—
5
13
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
90
3.20
7.20
1.1
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
78
412
2.00
7.04
6.2
4.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
43
4.27
7.04
1.3
2.0
e9/l
1.2
1.1
0.06
12
19
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
66
3.57
7.04
1.2
1.2
u/ml
1.9
3.8
—
7
33
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
38
149
2.64
6.88
1.6
1.4
—
—
—
0
0
(3019225) pH of Specimen
105
621
1.81
6.73
10.1
3.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
27
89
3.11
6.68
1.8
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
45
4.08
6.65
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
59
3.64
6.63
4.3
3.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
21
5.79
6.60
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
65
3.46
6.46
2.2
1.5
%
62.0
62.9
0.04
17
45
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
10
7
14.46
6.41
4.8
4.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
51
3.80
6.40
2.4
1.3
%
31.3
26.9
0.17
13
33
(3016018) Differential panel - Cerebral spinal fluid
16
39
4.17
6.11
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
30
111
2.78
6.09
1.4
1.2
u/l
31.3
47.2
0.43
25
95
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
68
3.31
6.04
2.0
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
170
1176
1.58
6.02
3.3
3.0
mmol/l
2.5
2.5
2.76
150
1031
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
31
4.59
6.00
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
261
2.11
5.79
2.2
2.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
24
5.07
5.76
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
228
2.18
5.75
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
92
2.89
5.73
1.1
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
46
3.76
5.67
3.1
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
46
3.76
5.67
1.5
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
46
3.76
5.67
1.1
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
482
1.82
5.64
2.6
2.5
u/l
45.0
31.6
1.18
71
406
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
42
3.87
5.56
1.3
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
29
111
2.68
5.54
1.4
1.3
e6/l
2181.4
1110.1
0.24
21
91
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
111
2.68
5.54
1.3
1.2
e6/l
15.9
31.7
0.22
21
87
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
38
4.01
5.46
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
92
2.78
5.15
1.4
1.1
u/ml
221.9
308.4
0.68
17
54
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
392
3287
1.42
5.07
3.9
3.0
u/l
64.4
49.8
1.68
367
3009
(4306422)
18
55
3.33
5.05
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
66
3.09
4.98
1.2
1.2
u/ml
1.2
1.9
—
5
27
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
90
2.72
4.79
2.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
48
249
1.99
4.61
1.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
148
2.29
4.57
1.4
1.4
ug/g
231.0
284.6
0.84
20
95
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
8
10.09
4.53
1.3
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
602
5515
1.53
4.51
38.0
14.2
mg/l
25.2
26.2
0.36
535
4364
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
469
4108
1.40
4.42
4.2
3.7
pmol/l
15.1
15.0
0.68
428
3663
(3025941) Bacteria identified in Stool by Culture
49
263
1.93
4.28
1.6
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
114
777
1.55
4.23
1.2
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
16
51
3.19
4.23
1.2
1.4
u/l
12.9
13.8
0.17
16
46
(3035933) Granulocytes/100 leukocytes in Blood
9
13
6.99
4.17
1.2
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
10
8.07
4.07
1.1
1.1
—
—
—
0
0
(3013512) EKG study
230
1813
1.39
4.02
5.7
3.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
48
3.17
3.95
2.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
70
2.76
3.94
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
44
237
1.91
3.83
2.7
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
29
3.84
3.81
2.3
1.8
—
—
—
0
0
(4027681)
11
29
3.84
3.81
1.5
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
29
3.84
3.81
1.5
1.8
u/ml
502.2
1540.2
1.59
11
29
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
128
2.24
3.75
1.7
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
16
5.68
3.66
2.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
40
3.29
3.64
1.2
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
35
3.47
3.63
2.1
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
35
3.47
3.63
1.3
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
22
92
2.43
3.59
4.5
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
454
4022
1.34
3.58
6.2
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
326
2755
1.33
3.55
2.8
2.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
46
3.08
3.54
1.1
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
6
10.07
3.50
7.3
7.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
31
3.59
3.49
1.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
36
3.37
3.49
2.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
82
2.48
3.41
1.6
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
18
5.05
3.38
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
95
2.36
3.36
1.8
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
547
5008
1.37
3.34
5.1
4.5
mu/l
2.1
2.0
1.08
500
4480
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
34
177
1.97
3.29
1.5
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
43
3.06
3.26
1.6
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
43
3.06
3.26
2.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
60
2.70
3.24
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
49
2.89
3.20
1.1
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
11
6.41
3.19
1.4
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
74
488
1.57
3.19
6.6
3.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
81
548
1.54
3.12
1.9
2.2
ug/g
123.6
133.5
0.15
70
424
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
8
7.55
3.06
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
29
3.48
3.05
1.1
1.0
nmol/l
113.7
131.4
—
10
29
(3011648) Oxygen content in Venous blood
10
29
3.48
3.05
2.8
1.4
%
9.6
10.7
—
10
29
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
154
1.99
3.04
2.7
3.1
nmol/l
1.1
0.8
1.32
18
121
(3023410) Appearance of Cerebral spinal fluid
12
40
3.03
2.98
1.3
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
5
10.06
2.98
7.4
6.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
525
4812
1.33
2.93
34.6
15.7
%
37.9
39.3
2.49
332
3091
(3000093) Morphology [Interpretation] in Blood Narrative
14
52
2.73
2.90
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
157
1.95
2.89
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
179
1.88
2.87
1.7
1.5
iu/ml
0.0
0.1
—
8
34
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
117
867
1.42
2.87
1.3
1.2
iu/ml
33.2
40.3
0.34
44
275
(40761535) Cells panel - Urine sediment
77
526
1.52
2.85
4.9
3.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
18
4.48
2.80
4.8
2.5
u/l
207.4
202.9
—
8
18
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
18
4.48
2.80
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
18
4.48
2.80
1.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
6
8.38
2.75
1.0
1.0
umol/l
19.8
15.8
—
5
6
(3030981) Hyaline casts [#/volume] in Urine by Automated count
49
304
1.66
2.72
3.7
2.4
e6/l
0.2
0.3
0.66
49
296
(3045424) Erythrocytes [Presence] in Urine
20
92
2.21
2.69
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
80
2.28
2.62
1.7
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
20
4.03
2.57
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
164
1.86
2.57
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
81
2.25
2.55
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
81
2.25
2.55
1.7
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
33
3.06
2.53
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
296
0.43
2.49
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
82
2.23
2.49
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
82
2.23
2.49
1.7
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
12
5.03
2.40
6.5
6.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
27
3.36
2.40
2.2
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
8
6.28
2.37
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
103
773
1.39
2.36
1.4
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
29
3.13
2.23
5.8
18.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.58
2.21
1.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
9
5.58
2.21
1.8
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
24
3.36
2.18
7.4
3.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
24
3.36
2.18
1.3
1.5
—
—
—
0
0
(4094501)
26
144
1.84
2.17
1.1
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
14
4.31
2.15
3.2
5.4
%
55.3
50.8
—
6
14
(3014051) Protein [Presence] in Urine by Test strip
23
123
1.90
2.13
3.9
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
88
2.07
2.13
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
21
3.36
1.97
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
169
1401
1.27
1.94
1.4
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
478
4430
1.23
1.91
43.4
17.6
%
14.4
13.8
12.02
471
4316
(3026389) Candida sp identified in Specimen by Organism specific culture
14
65
2.18
1.89
1.2
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
12
52
2.33
1.88
1.1
1.1
g/l
2.0
1.5
2.01
12
46
(3004451) EKG impression Narrative
7
22
3.20
1.88
1.6
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
22
3.20
1.88
1.1
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
10
40
2.52
1.84
1.0
1.5
—
290.0
—
0
5
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
35
2.59
1.80
2.6
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
23
3.06
1.80
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
157
1303
1.26
1.78
1.7
1.7
pmol/l
52381434.4
21327453.2
0.25
126
1055
(3016244) Insulin [Units/volume] in Serum or Plasma
6
18
3.35
1.75
1.3
3.3
mu/l
47.5
14.4
—
6
18
(3035320) C reactive protein [Mass/volume] in Body fluid
8
30
2.68
1.72
2.6
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
106
842
1.30
1.70
1.2
1.2
u/ml
46.4
14.0
1.13
33
313
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
479
1.39
1.70
2.2
1.8
%
1.5
1.5
0.14
50
408
(3020891) Body temperature
37
244
1.54
1.68
5.1
4.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
42
2.40
1.68
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
42
2.40
1.68
1.2
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
182
1547
1.24
1.67
6.6
4.0
estimate
0.0
0.0
0.00
73
507
(3033799) Differential panel - Peritoneal fluid
6
19
3.18
1.66
1.2
2.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
16
83
1.95
1.65
2.9
1.6
mu/l
218.8
245.3
0.32
16
72
(3034426) Prothrombin time (PT)
5
14
3.59
1.62
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
26
2.71
1.58
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
57
2.12
1.55
1.2
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
609
5844
1.26
1.51
40.3
16.6
mmol/l
139.0
139.7
8.41
596
5659
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
58
2.09
1.50
2.2
1.6
u/l
1628.0
3201.1
—
5
18
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
65
2.02
1.49
3.2
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
548
5204
1.22
1.48
6.3
5.7
mmol/mol
39.7
39.8
0.07
505
4728
(3023103) Potassium [Moles/volume] in Serum or Plasma
610
5860
1.25
1.46
42.0
16.7
mmol/l
4.0
4.0
3.03
594
5669
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
126
1051
1.24
1.37
1.2
1.2
u/ml
3.1
1.4
0.33
23
261
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
41
2.21
1.37
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
41
2.21
1.37
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
41
2.21
1.37
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
42
2.16
1.34
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
42
2.16
1.34
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
42
2.16
1.34
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
170
1467
1.21
1.34
5.4
3.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
54
2.05
1.33
1.7
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
8
34
2.37
1.29
1.9
2.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
34
2.37
1.29
1.0
1.1
u/l
212.8
83.3
—
8
26
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
34
2.37
1.29
1.0
1.1
u/l
160.8
20.4
—
8
25
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
35
2.30
1.27
3.8
3.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
544
5193
1.19
1.24
4.9
3.9
mmol/l
1.3
1.2
1.81
490
4623
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
45
2.01
1.23
1.1
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
56
1.98
1.22
3.1
2.8
nmol/l
15.3
3.1
0.85
11
56
(3020961) Endomysium IgA Ab [Titer] in Serum
30
205
1.48
1.22
1.1
1.1
—
241.7
—
0
6
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.22
1.2
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
19
2.64
1.22
2.4
2.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.22
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
19
2.64
1.22
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
48
359
1.36
1.20
4.0
3.0
e9/l
4.3
4.0
0.40
34
265
(36660697) Celiac disease serology panel - Serum
49
368
1.36
1.19
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
594
5722
1.21
1.19
32.2
13.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
57
1.94
1.17
1.2
1.4
nmol/l
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
80
646
1.27
1.17
1.3
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
20
2.51
1.15
6.0
4.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
248
2238
1.16
1.15
4.7
5.3
ug/l
2.6
3.6
0.90
220
1983
(1761868) Lipid panel - Serum or Plasma
152
1737
0.84
1.11
3.0
2.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
21
2.39
1.09
1.0
1.1
—
50.5
—
0
6
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
137
1.55
1.06
2.9
2.5
ug/min
155.3
88.3
—
10
76
(3004616) Nuclear Ab [Presence] in Serum
12
67
1.80
1.05
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
51
395
1.31
1.04
3.7
3.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
235
2127
1.15
1.04
6.1
4.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
19
122
1.57
1.03
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
47
1.93
1.02
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
53
1.90
1.01
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
48
1.89
1.00
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
115
1.58
1.00
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
25
354
0.70
1.00
1.8
1.8
—
—
—
0
0
(4211845)
5
23
2.18
0.98
6.0
3.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
116
1.57
0.97
1.1
1.2
—
1.6
—
0
10
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
85
1.66
0.95
1.1
1.2
—
—
—
0
0
(4268621)
9
51
1.77
0.94
2.9
2.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
36
269
1.36
0.94
1.4
1.3
u/ml
140.8
182.7
0.37
36
246
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
242
0.65
0.90
1.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
91
771
1.21
0.89
4.1
4.5
%
32.9
32.4
0.19
74
505
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
153
1.45
0.86
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
153
1.45
0.86
1.4
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
31
1.94
0.84
1.2
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
154
1.44
0.84
1.4
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
51
628
0.80
0.81
1.6
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
26
0.00
0.78
0.0
7.7
—
70.9
—
0
19
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
132
0.60
0.74
1.1
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
39
1.80
0.72
1.1
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
39
1.80
0.72
1.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
41
328
1.26
0.71
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
76
650
1.19
0.70
2.8
4.2
ug/l
3.2
32.9
1.62
62
546
(40768793) Breast Pathology biopsy report
17
118
1.45
0.70
1.1
1.3
—
—
—
0
0
(4034850)
12
179
0.66
0.67
23.9
12.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
541
5249
1.12
0.66
31.4
13.4
ml/min/173m2
67.6
75.8
10.40
477
4354
(3003327) Ova and parasites identified in Stool by Light microscopy
19
137
1.40
0.65
1.9
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
20
146
1.38
0.64
1.2
1.2
u/ml
28.4
6.9
—
5
26
(3022145) Colonoscopy Study observation
73
629
1.18
0.63
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
37
297
1.26
0.63
5.8
3.9
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
8
49
1.64
0.62
2.3
2.3
ug/l
2.3
2.3
—
8
40
(3026470) Cobalt [Mass/volume] in Blood
8
50
1.61
0.61
2.3
2.2
ug/l
4.0
4.0
—
8
42
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
16.4
—
1781.8
—
0
20
(1002224) Polysomnography panel
10
151
0.66
0.60
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
53
1.51
0.58
2.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
123
1.39
0.58
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
36
1.67
0.56
1.2
1.0
—
0.5
—
0
8
(4281824)
9
60
1.51
0.54
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
38
1.58
0.54
1.2
1.8
mmol/l
6.5
7.0
—
6
22
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
100
1.41
0.52
1.2
1.3
miu/ml
171.4
191.1
—
5
46
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
380
1.20
0.51
1.9
2.2
nmol/l
13.1
13.2
0.05
39
335
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
602
5907
1.11
0.48
22.0
10.3
u/l
23.6
24.6
1.34
578
5629
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
556
5435
1.10
0.48
5.3
4.4
mmol/l
4.4
4.6
6.77
508
4911
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
569
5571
1.10
0.47
5.8
4.9
mmol/l
2.5
2.7
5.05
520
4994
(3003740) Influenza virus B Ag [Presence] in Specimen
7
48
1.46
0.47
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
48
1.46
0.47
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
141
0.71
0.45
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
275
1.21
0.44
1.1
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.6
1.5
g/l
1.0
0.9
—
5
33
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
16
0.00
0.41
0.0
1.8
—
2.8
—
0
6
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
0.6
—
0
11
(3036071) Salmonella sp Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
85
772
1.11
0.39
12.8
7.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
37
1.35
0.37
2.8
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
299
0.83
0.36
1.3
1.2
iu/ml
120.8
132.9
—
8
122
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
549
5390
1.08
0.35
5.3
4.4
mmol/l
1.4
1.5
5.36
498
4831
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
91
1.32
0.34
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
74
1.36
0.32
1.4
2.2
—
—
—
0
0
(3000492) Spirometry study
49
438
1.13
0.31
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
189
1803
1.07
0.30
4.0
4.6
%
21.3
21.6
0.08
98
971
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
217
0.83
0.29
1.1
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1305
1.07
0.28
2.9
3.2
ug/l
0.7
0.8
0.62
106
938
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
142
1497
0.94
0.27
1.8
1.6
mmol/l
1.4
1.3
0.81
125
1212
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
73
1.24
0.25
1.1
1.1
—
17.6
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
226
1.16
0.25
1.5
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
75
1.20
0.25
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
23
200
1.15
0.22
4.9
4.1
mmol/l
3.9
3.9
0.37
23
189
(40768441) Liver Pathology biopsy report
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
127
1213
1.06
0.20
6.2
4.1
kg/l
1.0
1.0
0.30
25
178
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
30
270
1.12
0.19
1.8
3.6
u/ml
39.8
83.8
1.10
30
260
(3001019) Free T4 and TSH panel - Serum or Plasma
13
152
0.85
0.17
1.5
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
438
4442
0.96
0.17
45.2
19.2
g/l
329.0
331.5
6.70
431
4398
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
341
1.09
0.16
2.4
2.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
111
1.17
0.16
1.1
1.2
—
27.7
—
0
10
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
73
1.10
0.15
1.6
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
615
6106
1.05
0.15
50.8
21.3
e9/l
7.2
6.7
6.03
595
5884
(3024731) MCV [Entitic volume]
614
6103
1.04
0.12
50.6
21.2
fl
92.3
91.6
3.48
603
5971
(3007461) Platelets [#/volume] in Blood
614
6103
1.04
0.12
50.7
21.3
e9/l
242.6
242.2
0.04
597
5905
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
18
162
1.11
0.12
1.7
1.6
mg/l
2.4
2.5
0.03
13
121
(3035941) MCH [Entitic mass]
614
6104
1.04
0.11
50.5
21.2
pg
30.5
30.4
0.50
603
5971
(3026361) Erythrocytes [#/volume] in Blood
614
6105
1.04
0.11
50.8
21.3
e12/l
4.2
4.4
15.61
594
5886
(3000963) Hemoglobin [Mass/volume] in Blood
614
6108
1.03
0.10
51.2
21.4
g/l
127.4
134.1
20.05
604
5973
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
114
0.88
0.09
1.7
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
56
1.07
0.08
2.8
3.6
u/ml
28.8
58.7
—
6
56
(4146454)
6
56
1.07
0.08
1.8
2.5
—
—
—
0
0
(4024509)
6
58
1.03
0.08
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
113
0.88
0.08
2.4
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
163
0.92
0.07
6.1
5.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
88
1.02
0.07
1.1
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
88
1.02
0.07
1.1
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
247
1.05
0.05
1.7
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
228
1.05
0.05
1.9
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
141
1.07
0.03
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
107
0.93
0.02
2.3
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
547
5479
0.99
0.01
5.3
4.7
mmol/l
5.9
6.0
0.54
490
4867
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
106
1.04
0.00
1.4
1.6
iu/l
2.5
4.3
—
6
29
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
137
1.02
0.00
1.6
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
51
515
0.99
0.00
1.3
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
63
0.95
0.00
1.5
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4010399)
41
410
1.00
0.00
1.5
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
66.2
—
0
6
(3027008) Opiates [Presence] in Urine
9
89
1.01
0.00
1.1
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
70
1.00
0.00
1.1
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
94
0.96
0.00
1.4
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
73
0.96
0.00
4.6
2.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
57
0.88
0.00
1.6
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
71
0.99
0.00
1.0
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
81
0.99
0.00
1.1
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
13.4
—
0
9
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
89
1.01
0.00
1.1
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_AMYLOIDOSIS – Amyloidosis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).